When these switches were applied to colon cancer cells, the cancer cells reverted to a normal-like state, a result confirmed through molecular and cellular experiments as well as animal studies.

Professor Kwang-Hyun Cho remarked, "The fact that cancer cells can be converted back to normal cells is an astonishing phenomenon. This study proves that such reversion can be systematically induced." ...

These regulators are known as MYB, HDAC2, and FOXA2 and when they were suppressed in colon cancer cells, the cells switched back to a normal-like state, removing the cancer threat without ...

When these switches were applied to colon cancer cells, the cancer cells reverted to a normal-like state, a result confirmed through molecular and cellular experiments as well as animal studies.

Laboratory experiments, including molecular and cellular studies, along with animal trials, confirmed that cancer cells could indeed be reverted to a state that closely resembles normal colon cells.

Colon cancer is relatively common in the U.S. The American Cancer Society (ACS) estimates that it's the third-most common cancer (excluding skin) and more than 106,000 people will be diagnosed ...

Once deleted PDZK1IP1 was deleted, colon cancer growth slowed down, suggesting that PDZK1IP1 and its super enhancer could be targets for anti-cancer therapies.

Professor Kwang-Hyun Cho's research team from the Department of Bio and Brain Engineering has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into ...